Cybin Archives

Psychedelics News

Cybin

Events

25 Oct 2021

Microdose Announces Cybin as Wonderland Bronze Sponsor

The leader in the business of psychedelics, Microdose is taking the next step in industry events with Wonderland: Miami....

By Microdose

Don’t Miss

25 Oct 2021

News You Might Have Missed: Oct 25, 2021

Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine industry news items to help you catch up and stay informed....

By Jason Najum

Press Releases

16 Feb 2021

Cybin Inc. Releases Financial Highlights and Provides Business Update

Successful bought deal offering brings total capital raised to-date to approximately $90 million Increased patent applications filed to 10, covering novel molecules, delivery systems, deuterated tryptamines and phenethylamines Adelia Therapeutics...

By Microdose

Press Releases

4 Feb 2021

Cybin Announces Closing of Upsized Bought Deal Offering

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ Official ReleaseCybin Inc....

By Microdose

Join Our Newsletter for Exclusive Updates, Stories, and More

Press Releases

19 Jan 2021

Cybin Announces Upsize to Previously Announced Bought Deal Offering

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ TORONTO, Jan....

By Microdose

Press Releases

18 Jan 2021

Cybin Announces CDN$20 Million Bought Deal Offering

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTOJan....

By Microdose

Press Releases

11 Jan 2021

Cybin Announces API Synthesis of Multiple Tryptamine Derivatives Based on the First Milestone Achievement Pursuant to the Adelia Acquisition

TORONTO, CANADA – January 11, 2021 – Cybin Inc....

By Microdose

Press Releases

11 Jan 2021

Cybin Partners with Kernel to Leverage its Breakthrough Neuroimaging Technology for Psychedelic Therapeutics

Using Kernel’s technology, Cybin will be able to quantify brain activity in real time during psychedelic experiences....

By Microdose

Press Releases

6 Jan 2021

Cybin Provides Update On Patent Filings & Development Of Therapeutics Program

BUSINESS WIRE)–Cybin Inc....

By Microdose

Follow us on social

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result